1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14(CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018, 391(1125): 1023-1075.
|
3. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
4. |
Luo JH, Chen YJ, Chang LJ. Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients. Lung Cancer, 2012, 76(2): 242-247.
|
5. |
Farrokhi F, Smiley D, Umpierrez GE. Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab, 2011, 25(5): 813-824.
|
6. |
Gao Y, Gao F, Ma JL, et al. Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients. Patient Prefer Adherence, 2015, 9: 1189-1194.
|
7. |
Detterbeck FC, Boffa DJ, Kim AW. The eighth edition lung cancer stage classification. Chest, 2017, 151(1): 193-203.
|
8. |
Travis WD, Brambilla E, Burke AP, et al. WHO Classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: International Agency for Research on Cancer, 2015: 9-96.
|
9. |
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998, 15(7): 539-553.
|
10. |
Parés-Badell O, Banqué M, Macià F, et al. Impact of comorbidity on survival by tumour location: breast, colorectal and lung cancer (2000-2014). Cancer Epidemiol, 2017(49): 66-74.
|
11. |
Storey S, Von Ah D, Hammer MJ. Measurement of hyperglycemia and impact on health outcomes in people with cancer: challenges and opportunities. Oncol Nurs Forum, 2017, 44(4): E141-E151.
|
12. |
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324(5930): 1029-1033.
|
13. |
Han L, Ma Q, Li J, et al. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One, 2011, 6(11): e27074.
|
14. |
Ding CZ, Guo XF, Wang GL, et al. High glucose contributes to the proliferation and migration of non-small cell lung cancer cells via GAS5-TRIB3 axis. Biosci Rep, 2018, 38(2): BSR20171014.
|
15. |
于露, 梁良. 高血糖对肺癌患者肺功能的影响. 现代医药卫生, 2018, 34(11): 1699-1700.
|
16. |
van de Poll-Franse DV, Houterman S, Janssen-Heijnen ML, et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer, 2007, 120(9): 1986-1992.
|